About Pagari Life Science
Pagari Life Science is a private company based in Bethalta, Illinois, incorporated in 2022 in Delaware. It has reported $677,994 raised in four offerings on Form D since October 2023. Its chief executive is David Feldker.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | May 12, 2026 | $97,494of $300K target | 8 | $12,187 | EquityRule 506(b) | Form D ↗ |
| May 23, 2025 | May 29, 2025 | $55,500of $4.0M target | 6 | $9,250 | EquityRule 506(b) | Form D ↗ |
| Mar 26, 2024 | Apr 8, 2024 | $275,000of $600K target | 2 | $137K | EquityRule 506(b) | Form D ↗ |
| Oct 13, 2023 | Oct 27, 2023 | $250,000of $450K target | 3 | $83,333 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $677,994 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pagari Life Science's Form D filed May 12, 2026.
Earlier filings also listed Alan Wickenhauser (director, last listed Apr 2024) and Stephen Piepert (director, last listed Oct 2023).